PMH12 COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE 3-MONTH VERSUS 1-MONTH FOR THE TREATMENT OF SCHIZOPHRENIA IN THE UNITED STATES
May 1, 2019, 00:00
10.1016/j.jval.2019.04.1057
https://www.valueinhealthjournal.com/article/S1098-3015(19)31249-5/fulltext
Title :
PMH12 COST-EFFECTIVENESS OF PALIPERIDONE PALMITATE 3-MONTH VERSUS 1-MONTH FOR THE TREATMENT OF SCHIZOPHRENIA IN THE UNITED STATES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)31249-5&doi=10.1016/j.jval.2019.04.1057
First page :
Section Title :
Open access? :
No
Section Order :
10589